CD44 Splice Variant v8-10 as a Marker of Serous Ovarian Cancer Prognosis

Author:

Sosulski Amanda,Horn Heiko,Zhang Lihua,Coletti Caroline,Vathipadiekal Vinod,Castro Cesar M.,Birrer Michael J.,Nagano Osamu,Saya Hideyuki,Lage Kasper,Donahoe Patricia K.,Pépin David

Funder

Commons Development

Austen Fund

McBride Family

Sudna Gar

Massachusetts General Hospital

Publisher

Public Library of Science (PLoS)

Subject

Multidisciplinary

Reference33 articles.

1. Correlation of CD44v6 expression with ovarian cancer progression and recurrence;J Shi;BMC Cancer,2013

2. Mechanism and biological significance of CD44 cleavage;O Nagano;Cancer Sci,2004

3. Splice variant expression of CD44 in patients with breast and ovarian cancer;Lockhart M Sanchez;Oncol Rep,2001

4. Anti-tumor effect against human cancer xenografts by a fully human monoclonal antibody to a variant 8-epitope of CD44R1 expressed on cancer stem cells;K Masuko;PLoS One,2012

5. CD44: from adhesion molecules to signalling regulators;H Ponta;Nat Rev Mol Cell Biol,2003

Cited by 41 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3